Statins and blood pressure drugs changing health risks of obesity, study suggests - Summary - MDSpire

Statins and blood pressure drugs changing health risks of obesity, study suggests

  • By

  • Elizabeth Cooney

  • July 1, 2026

  • 0 min

Share

Objective:

To examine the cardiovascular health of individuals with obesity compared to those with normal weight, particularly focusing on blood pressure and cholesterol levels over a 25-year period, and the impact of statins and antihypertensives.

Approach:
  • Study Design: The study was observational, analyzing blood pressure and cholesterol readings from 1 million participants across seven countries from 1990 to 2024.
  • Population: Participants included adults aged 40 to 79 with varying BMIs, focusing on the impact of statins and antihypertensives.
Key Findings:
  • Blood pressure and unhealthy cholesterol levels decreased more significantly among adults with obesity aged 40 to 79 compared to those with normal BMI, likely due to increased use of statins and antihypertensives.
  • By 2024, older adults with obesity had similar or lower blood pressure and cholesterol levels than their normal BMI peers.
  • Younger adults under 40 did not show similar improvements, likely due to less screening and treatment.
Interpretation:

The findings suggest that medical management through statins and antihypertensives has improved cardiovascular risk factors in older adults with obesity, but obesity remains a significant health risk.

Limitations:
  • The study's observational nature prevents establishing cause and effect.
  • Changes in blood pressure and cholesterol were less pronounced in certain countries like Taiwan and Thailand.
Conclusion:

While older adults with obesity are experiencing improved cardiovascular risk factors, younger adults are not benefiting similarly, raising concerns about their long-term health.

Sources:

Original Source(s)

Statins and blood pressure drugs changing health risks of obesity, study suggests

  • by Elizabeth Cooney

  • July 1, 2026

Related Content

What Referring Physicians Need to Know About Current Peripheral Artery Disease Guidelines

Peripheral artery disease (PAD) affects millions of Americans, yet many patients remain undiagnosed until symptoms become severe.

  • by

  • June 22, 2026

  • 4 min
Comorbidity sequence, sex, and APOE-genotype forecast Alzheimer's disease diagnosis

Coronary Model Shows Limits in Cath-Referred Patients

An interpretable machine-learning model classified angiographic coronary artery disease in patients referred for coronary angiography, but high disease prevalence and unclear inflammatory signals limited clinical interpretation.